Cargando…
Tescalcin is an unfavorable prognosis factor that regulats cell proliferation and survival in hepatocellular carcinoma patients
BACKGROUND: Hepatocellular carcinoma (HCC) is a major health problem and a primary cause of cancer‐related death worldwide. Although great advances have achieved recently by large‐scale high‐throughput analysis, the precise molecular mechanism underlying HCC progression remains to be clearly elucida...
Autores principales: | Zhou, Zhong‐Guo, Chen, Jin‐Bin, Zhang, Rong‐Xin, Ye, Ling, Wang, Jun‐Cheng, Pan, Yang‐Xun, Wang, Xiao‐Hui, Li, Wen‐Xuan, Zhang, Yao‐Jun, Xu, Li, Chen, Min‐Shan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7427307/ https://www.ncbi.nlm.nih.gov/pubmed/32609436 http://dx.doi.org/10.1002/cac2.12069 |
Ejemplares similares
-
Peroxiredoxin2 downregulation enhances hepatocellular carcinoma proliferation and migration, and is associated with unfavorable prognosis in patients
por: Bai, Bing, et al.
Publicado: (2019) -
Overexpression of WWP1 Promotes tumorigenesis and predicts unfavorable prognosis in patients with hepatocellular carcinoma
por: Zhang, Xiao-Fei, et al.
Publicado: (2015) -
Tescalcin promotes highly invasive papillary thyroid microcarcinoma by regulating FOS/ERK signaling pathway
por: Zou, Xiuhe, et al.
Publicado: (2022) -
The EF-hand calcium-binding protein tescalcin is a potential oncotarget in colorectal cancer
por: Hee Kang, Yun, et al.
Publicado: (2014) -
Highly expressed carbohydrate sulfotransferase 11 correlates with unfavorable prognosis and immune evasion of hepatocellular carcinoma
por: Xiong, Dan‐dan, et al.
Publicado: (2022)